{"id":"NCT00966264","sponsor":"University of Helsinki","briefTitle":"Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia","officialTitle":"Hysterectomy and Levonorgestrel-releasing IUS in the Treatment of Menorrhagia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1994-10","primaryCompletion":"2008-10","completion":"2008-10","firstPosted":"2009-08-26","resultsPosted":"2009-08-26","lastUpdate":"2009-09-02"},"enrollment":236,"design":{"allocation":"RANDOMIZED","model":"FACTORIAL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Menorrhagia"],"interventions":[{"type":"DRUG","name":"LNG-IUS","otherNames":["Mirena"]},{"type":"PROCEDURE","name":"Hysterectomy","otherNames":["Removal of uterus by laparoscopy, vaginally or abdominally"]}],"arms":[{"label":"LNG-IUS","type":"ACTIVE_COMPARATOR"},{"label":"Hysterectomy","type":"OTHER"}],"summary":"A randomised study including 236 women referred for essential menorrhagia to five university hospitals in Finland was conducted to compare the cost-effectiveness and the quality of life issues in the treatment of menorrhagia.Participants were randomly assigned to treatment with LNG-IUS (n=119), or hysterectomy (n=117), and were monitored for ten years. The primary outcome measures were health related quality of life (HRQoL), other measures of psychosocial well-being (anxiety, depression, sexual functioning), and costs.","primaryOutcome":{"measure":"HRQoL (Health Related Quality of Life)","timeFrame":"baseline and 5 years","effectByArm":[{"arm":"LNG-IUS","deltaMin":0.08,"sd":null},{"arm":"Hysterectomy","deltaMin":0.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"35 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":13},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0},"commonTop":["menstrual bleeding problems","wund infection","hormonal symptoms","urinary retention","postoperative bleeding"]}}